286 related articles for article (PubMed ID: 28029471)
1. Treatment of Clostridium difficile infection: a national survey of clinician recommendations and the use of faecal microbiota transplantation.
Prior AR; Kevans D; McDowell L; Cudmore S; Fitzpatrick F
J Hosp Infect; 2017 Apr; 95(4):438-441. PubMed ID: 28029471
[TBL] [Abstract][Full Text] [Related]
2. Faecal microbiota transplantation for Clostridium difficile infection in the United Kingdom.
Porter RJ; Fogg C
Clin Microbiol Infect; 2015 Jun; 21(6):578-82. PubMed ID: 25677629
[TBL] [Abstract][Full Text] [Related]
3. Faecal microbiota transplantation in recurrent Clostridium difficile infection: Recommendations from the French Group of Faecal microbiota Transplantation.
Sokol H; Galperine T; Kapel N; Bourlioux P; Seksik P; Barbut F; Scanzi J; Chast F; Batista R; Joly F; Joly AC; Collignon A; Guery B; Beaugerie L;
Dig Liver Dis; 2016 Mar; 48(3):242-7. PubMed ID: 26433619
[TBL] [Abstract][Full Text] [Related]
4. First implementation of frozen, capsulized faecal microbiota transplantation for recurrent Clostridium difficile infection into clinical practice in Europe.
Tacke D; Wisplinghoff H; Kretzschmar A; Farowski F; Koehler P; Herweg J; Cornely OA; Vehreschild MJ
Clin Microbiol Infect; 2015 Nov; 21(11):e82-4. PubMed ID: 26163107
[No Abstract] [Full Text] [Related]
5. Pulsed faecal microbiota transplantation for recalcitrant recurrent Clostridium difficile infection.
Porter RJ
Clin Microbiol Infect; 2015 Mar; 21(3):e23-4. PubMed ID: 25658573
[No Abstract] [Full Text] [Related]
6. Faecal microbiota transplantation as salvage therapy for fulminant Clostridium difficile infections.
Million M; Hocquart M; Seghboyan JM; Griffiths K; Halfon P; Lagier JC; Brouqui P; Raoult D
Int J Antimicrob Agents; 2015 Aug; 46(2):227-8. PubMed ID: 26092095
[No Abstract] [Full Text] [Related]
7. [Faecal transplantation as a treatment for Clostridium difficile infection, ulcerative colitis and the metabolic syndrome].
Carstensen JW; Hansen AK
Ugeskr Laeger; 2014 Feb; 176(4):. PubMed ID: 25095865
[TBL] [Abstract][Full Text] [Related]
8. Fecal microbiota transplantation for Clostridium difficile-associated colitis in a severely immunocompromized critically ill AIDS patient: a case report.
Schünemann M; Oette M
AIDS; 2014 Mar; 28(5):798-9. PubMed ID: 24983544
[No Abstract] [Full Text] [Related]
9. [Fecal microbiota transplant in the treatment of recurrent Clostridium difficile infection: A case report].
Haemers I; Delvallée M
Rev Med Brux; 2016; 37(3):174-177. PubMed ID: 28525191
[TBL] [Abstract][Full Text] [Related]
10. Novel therapies for severe Clostridium difficile colitis.
Waltz P; Zuckerbraun B
Curr Opin Crit Care; 2016 Apr; 22(2):167-73. PubMed ID: 26771898
[TBL] [Abstract][Full Text] [Related]
11. Faecal Microbiota Transplantation for Clostridium Difficile - a local perspective.
Diamond C; McNeilly T
Ulster Med J; 2017 May; 86(2):108-110. PubMed ID: 29535482
[TBL] [Abstract][Full Text] [Related]
12. Faecal microbiota transplantation for Clostridium difficile infection: a multicentre study of non-responders.
Razik R; Osman M; Lieberman A; Allegretti JR; Kassam Z
Med J Aust; 2017 Aug; 207(4):159-160. PubMed ID: 28814217
[No Abstract] [Full Text] [Related]
13. Faecal microbiota transplantation for recurrent Clostridium difficile infection and beyond: risks and regulation.
Goldenberg SD
J Hosp Infect; 2016 Feb; 92(2):115-6. PubMed ID: 26792682
[No Abstract] [Full Text] [Related]
14. Faecal microbiota transplantation: a regulatory hurdle?
Verbeke F; Janssens Y; Wynendaele E; De Spiegeleer B
BMC Gastroenterol; 2017 Nov; 17(1):128. PubMed ID: 29179687
[TBL] [Abstract][Full Text] [Related]
15. [Fecal microbiota transplantation: indications and perspectives].
Lagier JC; Raoult D
Med Sci (Paris); 2016 Nov; 32(11):991-997. PubMed ID: 28008840
[TBL] [Abstract][Full Text] [Related]
16. Novel approaches to treating Clostridium difficile-associated colitis.
Padua D; Pothoulakis C
Expert Rev Gastroenterol Hepatol; 2016; 10(2):193-204. PubMed ID: 26643655
[TBL] [Abstract][Full Text] [Related]
17. Treatment approaches including fecal microbiota transplantation for recurrent Clostridium difficile infection (RCDI) among infectious disease physicians.
Bakken JS; Polgreen PM; Beekmann SE; Riedo FX; Streit JA
Anaerobe; 2013 Dec; 24():20-4. PubMed ID: 24012687
[TBL] [Abstract][Full Text] [Related]
18. Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection.
Brown JR; Flemer B; Joyce SA; Zulquernain A; Sheehan D; Shanahan F; O'Toole PW
BMC Gastroenterol; 2018 Aug; 18(1):131. PubMed ID: 30153805
[TBL] [Abstract][Full Text] [Related]
19. Systematic review with meta-analysis: long-term outcomes of faecal microbiota transplantation for Clostridium difficile infection.
Li YT; Cai HF; Wang ZH; Xu J; Fang JY
Aliment Pharmacol Ther; 2016 Feb; 43(4):445-57. PubMed ID: 26662643
[TBL] [Abstract][Full Text] [Related]
20. Laboratory Testing of Donors and Stool Samples for Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
Woodworth MH; Neish EM; Miller NS; Dhere T; Burd EM; Carpentieri C; Sitchenko KL; Kraft CS
J Clin Microbiol; 2017 Apr; 55(4):1002-1010. PubMed ID: 28077694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
